In this study we jointly used the key component of tumor-infiltrating lymphocytes (TILs) which are CD8+ T cells (known as cytotoxic T cell, immune active factor) and PD-L1 expression (immune inhibitory factor) as the criteria to classify gastric cancer. The gene discussed is CD8A; the disease is neoplasm.